Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2012


Metabolomics in Drug Development and Discovery

18 Sep 2012 - 20 Sep 2012 - Boston, USA



Bookmark and Share


Metabolomics provide the ultimate answer to how genetic alterations, disease and environmental influences impact in vivo biology and drug action. That is why, increasingly, drug developers are embracing the benefits of using metabolomics to enhance all aspects of development, from lead discovery right through to post approval surveillance.
Uncovering new drug targets. Identifying safety & efficacy biomarkers. Using pharmaco-metabolomic data in clinical trial design.

Make sure you stay abreast of the last progress and start applying metabolomics to your pipeline.

Metabolomics in Drug Discovery & Development is the world’s only commercially focussed metabolomics meeting. Bringing together the industry leaders to debate what challenges still remain and what stages of drug development can benefit most.

What will you gain from attending?

  • You will improve your knowledge of current metabolomic techniques in target identification & validation
  • Get a detailed understanding of how metabolomics can be used to reduce costs & time and improve safety of your clinical development
  • Hear in-depth studies on how pharmaceutical companies and leading innovators are applying metabolomics to understand biological variability
  • Receive an update on how the FDA are preparing for the use of metabolomics and biomarker data in drug submissions
  • Learn which technologies and services are helping to analyze complex metabolomic data sets and discover new biomarkers


Further information
Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Apricot Kernels Pose Risk of Cyanide Poisoning
Eating more than three small raw apricot kernels, or less than half of one large kernel, in a serving can exceed safe levels. Toddlers consuming even one small apricot kernel risk being over the safe level.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Genetic Markers Influence Addiction
Differences in vulnerability to cocaine addiction and relapse linked to both inherited traits and epigenetics, U-M researchers find.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
A lncRNA Regulates Repair of DNA Breaks in Breast Cancer Cells
Findings give "new insight" into biology of tough-to-treat breast cancer.
COPD Linked to Increased Bacterial Invasion
Persistent inflammation in COPD may result from a defect in the immune system that allows airway bacteria to invade deeper into the lung.
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!